1	Cloning	Cloning	B-NP	NN	O	11	NMOD
2	,	,	O	,	O	11	P
3	expression	expression	B-NP	NN	O	11	NMOD
4	,	,	O	,	O	11	P
5	purification	purification	B-NP	NN	O	11	NMOD
6	,	,	O	,	O	11	P
7	crystallization	crystallization	B-NP	NN	O	11	NMOD
8	and	and	O	CC	O	11	NMOD
9	X-ray	X-ray	B-NP	NN	O	11	NMOD
10	crystallographic	crystallographic	I-NP	JJ	O	11	NMOD
11	analysis	analysis	I-NP	NN	O	0	ROOT
12	of	of	B-PP	IN	O	11	NMOD
13	Rv3168	Rv3168	B-NP	NN	O	12	PMOD
14	from	from	B-PP	IN	O	13	NMOD
15	Mycobacterium	Mycobacterium	B-NP	NN	O	17	NMOD
16	tuberculosis	tuberculosis	I-NP	NN	O	17	NMOD
17	H37Rv	H37Rv	I-NP	NN	O	14	PMOD
18	.	.	O	.	O	11	P

1	Tuberculosis	Tuberculosis	B-NP	NN	O	2	SUB
2	is	be	B-VP	VBZ	O	0	ROOT
3	a	a	B-NP	DT	O	8	NMOD
4	widespread	widespread	I-NP	JJ	O	8	NMOD
5	and	and	I-NP	CC	O	8	NMOD
6	deadly	deadly	I-NP	JJ	O	8	NMOD
7	infectious	infectious	I-NP	JJ	O	8	NMOD
8	disease	disease	I-NP	NN	O	2	PRD
9	,	,	O	,	O	8	P
10	with	with	B-PP	IN	O	8	NMOD
11	one	one	B-NP	CD	O	12	NMOD
12	third	third	I-NP	NN	O	10	PMOD
13	of	of	B-PP	IN	O	12	NMOD
14	the	the	B-NP	DT	O	16	NMOD
15	human	human	I-NP	JJ	O	16	NMOD
16	population	population	I-NP	NN	O	13	PMOD
17	already	already	B-VP	RB	O	18	VMOD
18	being	be	I-VP	VBG	O	8	NMOD
19	infected	infect	I-VP	VBN	O	18	VC
20	.	.	O	.	O	2	P

1	Aminoglycoside	Aminoglycoside	B-NP	NN	O	2	NMOD
2	antibiotics	antibiotic	I-NP	NNS	O	3	SUB
3	have	have	B-VP	VBP	O	0	ROOT
4	become	become	I-VP	VBN	O	3	VC
5	less	less	B-ADJP	RBR	O	6	AMOD
6	effective	effective	I-ADJP	JJ	O	4	PRD
7	in	in	B-PP	IN	O	4	VMOD
8	recent	recent	B-NP	JJ	O	9	NMOD
9	years	year	I-NP	NNS	O	7	PMOD
10	owing	owe	B-VP	VBG	O	9	NMOD
11	to	to	B-PP	TO	O	10	VMOD
12	antibiotic	antibiotic	B-NP	JJ	O	13	NMOD
13	resistance	resistance	I-NP	NN	O	11	PMOD
14	,	,	O	,	O	13	P
15	which	which	B-NP	WDT	O	13	NMOD
16	arises	arise	B-VP	VBZ	O	15	SBAR
17	primarily	primarily	B-ADVP	RB	O	16	VMOD
18	through	through	B-PP	IN	O	16	VMOD
19	enzymatic	enzymatic	B-NP	JJ	O	20	NMOD
20	modification	modification	I-NP	NN	O	18	PMOD
21	of	of	B-PP	IN	O	20	NMOD
22	the	the	B-NP	DT	O	23	NMOD
23	antibiotics	antibiotic	I-NP	NNS	O	21	PMOD
24	.	.	O	.	O	3	P

1	The	The	B-NP	DT	O	4	NMOD
2	gene	gene	I-NP	NN	O	4	NMOD
3	product	product	I-NP	NN	O	4	NMOD
4	Rv3168	Rv3168	I-NP	NN	O	9	NMOD
5	,	,	O	,	O	9	P
6	a	a	B-NP	DT	O	9	NMOD
7	putative	putative	I-NP	JJ	O	9	NMOD
8	aminoglycoside	aminoglycoside	I-NP	NN	O	9	NMOD
9	phosphotransferase	phosphotransferase	I-NP	NN	O	17	SUB
10	(	(	O	(	O	12	DEP
11	APH	APH	B-NP	NN	O	12	DEP
12	)	)	O	)	O	9	NMOD
13	,	,	O	,	O	9	P
14	from	from	B-PP	IN	O	9	NMOD
15	Mycobacterium	Mycobacterium	B-NP	NN	O	16	NMOD
16	tuberculosis	tuberculosis	I-NP	NN	O	14	PMOD
17	was	be	B-VP	VBD	O	0	ROOT
18	crystallized	crystallize	I-VP	VBN	O	17	VC
19	using	use	B-VP	VBG	O	18	VMOD
20	the	the	B-NP	DT	O	23	NMOD
21	sitting-drop	sitting-drop	I-NP	JJ	O	23	NMOD
22	vapour-diffusion	vapour-diffusion	I-NP	NN	O	23	NMOD
23	method	method	I-NP	NN	O	41	NMOD
24	in	in	B-PP	IN	O	23	NMOD
25	the	the	B-NP	DT	O	26	NMOD
26	presence	presence	I-NP	NN	O	24	PMOD
27	of	of	B-PP	IN	O	26	NMOD
28	0.2	0.2	B-NP	CD	O	29	AMOD
29	M	M	I-NP	NN	O	31	NMOD
30	calcium	calcium	I-NP	NN	O	31	NMOD
31	acetate	acetate	I-NP	NN	O	27	PMOD
32	,	,	O	,	O	41	P
33	0.1	0.1	B-NP	CD	O	34	AMOD
34	M	M	I-NP	NN	O	36	NMOD
35	Tris-HCl	Tris-HCl	I-NP	NN	O	36	NMOD
36	pH	pH	I-NP	NN	O	41	NMOD
37	7.0	7.0	B-NP	CD	O	36	NMOD
38	and	and	I-NP	CC	O	36	NMOD
39	20	20	I-NP	CD	O	36	NMOD
40	%	%	I-NP	NN	O	41	NMOD
41	PEG	PEG	I-NP	NN	O	19	OBJ
42	3000	3000	I-NP	CD	O	41	NMOD
43	at	at	B-PP	IN	O	41	NMOD
44	295	295	B-NP	CD	O	48	NMOD
45	K.	K.	I-NP	NNP	O	48	NMOD
46	X-ray	X-ray	I-NP	NNP	O	48	NMOD
47	diffraction	diffraction	I-NP	NN	O	48	NMOD
48	data	datum	I-NP	NNS	O	43	PMOD
49	were	be	B-VP	VBD	O	17	VMOD
50	collected	collect	I-VP	VBN	O	49	VC
51	to	to	B-PP	TO	O	50	VMOD
52	a	a	B-NP	DT	O	54	NMOD
53	maximum	maximum	I-NP	NN	O	54	NMOD
54	resolution	resolution	I-NP	NN	O	51	PMOD
55	of	of	B-PP	IN	O	54	NMOD
56	1.67	1.67	B-NP	CD	O	57	NMOD
57	Å	Å	I-NP	NN	O	55	PMOD
58	on	on	B-PP	IN	O	54	NMOD
59	a	a	B-NP	DT	O	61	NMOD
60	synchrotron	synchrotron	I-NP	NN	O	61	NMOD
61	beamline	beamline	I-NP	NN	O	58	PMOD
62	.	.	O	.	O	17	P

1	The	The	B-NP	DT	O	2	NMOD
2	crystal	crystal	I-NP	NN	O	3	SUB
3	belonged	belong	B-VP	VBD	O	0	ROOT
4	to	to	I-VP	TO	O	5	VMOD
5	space	space	I-VP	VB	O	3	VMOD
6	group	group	B-NP	NN	O	7	NMOD
7	P2	P2	I-NP	NN	O	16	NMOD
8	(	(	O	(	O	14	DEP
9	1	1	B-NP	CD	O	12	NMOD
10	)	)	O	)	O	12	NMOD
11	2	2	B-NP	CD	O	12	NMOD
12	(	(	I-NP	NN	O	14	DEP
13	1	1	B-NP	CD	O	12	NMOD
14	)	)	O	)	O	7	NMOD
15	2	2	B-NP	CD	O	16	NMOD
16	(	(	I-NP	NN	O	18	DEP
17	1	1	B-NP	CD	O	16	NMOD
18	)	)	O	)	O	5	VMOD
19	,	,	O	,	O	5	P
20	with	with	B-PP	IN	O	5	VMOD
21	unit-cell	unit-cell	B-NP	NN	O	22	NMOD
22	parameters	parameter	I-NP	NNS	O	20	PMOD
23	a	a	B-NP	DT	O	20	PMOD
24	=	=	I-NP	JJ	O	23	NMOD
25	56.74	56.74	I-NP	CD	O	24	AMOD
26	,	,	O	,	O	31	P
27	b	b	B-NP	NN	O	31	NMOD
28	=	=	B-VP	SYM	O	27	NMOD
29	62.37	62.37	B-NP	CD	O	28	AMOD
30	,	,	O	,	O	31	P
31	c	c	B-NP	NN	O	24	VMOD
32	=	=	B-VP	SYM	O	31	NMOD
33	103.61	103.61	B-NP	CD	O	34	NMOD
34	Å	Å	I-NP	NN	O	32	AMOD
35	.	.	O	.	O	3	P

1	With	With	B-PP	IN	O	21	VMOD
2	one	one	B-NP	CD	O	3	NMOD
3	molecule	molecule	I-NP	NN	O	1	PMOD
4	per	per	B-PP	IN	O	3	NMOD
5	asymmetric	asymmetric	B-NP	JJ	O	6	NMOD
6	unit	unit	I-NP	NN	O	4	PMOD
7	,	,	O	,	O	21	P
8	the	the	B-NP	DT	O	10	NMOD
9	crystal	crystal	I-NP	JJ	O	10	NMOD
10	volume	volume	I-NP	NN	O	21	SUB
11	per	per	B-PP	IN	O	10	NMOD
12	unit	unit	B-NP	NN	O	14	NMOD
13	protein	protein	I-NP	NN	O	14	NMOD
14	weight	weight	I-NP	NN	O	11	PMOD
15	(	(	O	(	O	20	DEP
16	V	V	B-NP	NN	O	20	DEP
17	(	(	O	(	O	19	DEP
18	M	M	B-NP	NN	O	19	DEP
19	)	)	O	)	O	16	NMOD
20	)	)	O	)	O	10	NMOD
21	is	be	B-VP	VBZ	O	0	ROOT
22	2.91	2.91	B-NP	CD	O	23	NMOD
23	Å	Å	I-NP	NN	O	27	NMOD
24	(	(	B-LST	(	O	25	DEP
25	3	3	I-LST	LS	O	27	NMOD
26	)	)	O	)	O	25	DEP
27	Da	Da	B-NP	NN	O	21	PRD
28	(	(	O	(	O	30	DEP
29	-1	-1	B-NP	CD	O	30	DEP
30	)	)	O	)	O	27	NMOD
31	.	.	O	.	O	21	P

1	The	The	B-NP	DT	O	2	NMOD
2	structure	structure	I-NP	NN	O	3	SUB
3	was	be	B-VP	VBD	O	17	VMOD
4	solved	solve	I-VP	VBN	O	3	VC
5	by	by	B-PP	IN	O	4	VMOD
6	the	the	B-NP	DT	O	10	NMOD
7	single-wavelength	single-wavelength	I-NP	JJ	O	10	NMOD
8	anomalous	anomalous	I-NP	JJ	O	10	NMOD
9	dispersion	dispersion	I-NP	NN	O	10	NMOD
10	method	method	I-NP	NN	O	12	NMOD
11	and	and	I-NP	CC	O	12	NMOD
12	refinement	refinement	I-NP	NN	O	5	PMOD
13	of	of	B-PP	IN	O	12	NMOD
14	the	the	B-NP	DT	O	16	NMOD
15	selenomethionine	selenomethionine	I-NP	NN	O	16	NMOD
16	structure	structure	I-NP	NN	O	13	PMOD
17	is	be	B-VP	VBZ	O	0	ROOT
18	in	in	B-PP	IN	O	17	PRD
19	progress	progress	B-NP	NN	O	18	PMOD
20	.	.	O	.	O	17	P

